In support of the coalition’s commitment to transparency, and with the permission of investigators, we are sharing study materials for COVID-19 clinical research, including protocols, participant information sheets and informed consent forms, case report forms, standard operating procedures, and other documents.
This material is intended to support other researchers to better understand the design and methodologies of proposed and existing studies, and to accelerate research planning by providing examples that may, where suitable, be adapted for other contexts.
If you would like to list your study on the coalition’s website, please contact us at firstname.lastname@example.org.
|Study name||Interventional or observational study||If interventional, product type||Additional details||Study region(s)||Gaps or needs to be met|
|ATOMIC2||Interventional||Therapeutics||Phase III||Europe, Asia, Latin America||Seeking clinical trial partners, sites|
|CAPE COD||Interventional||Therapeutics||Phase III||Europe|
|CODEX||Interventional||Therapeutics||Phase III||Latin America|
|COPCOV||Interventional||Therapeutics||Phase III, pre-exposure prophylaxis||Asia, Europe, Africa||Seeking clinical trial partners, sites|
|COVID-19 Critical Care Consortium Observational Study||Observational||–||All continents||Looking for for participating sites|
|COVID-19 PEP||Interventional||Therapeutics||Phase III||North America|
|Moderna||Interventional||Vaccines||Phase III||North America||-|
|REMAP CAP||Interventional||Therapeutics||Phase III||Multiple|
|Remdesivir||Interventional||Therapeutics||Phase III||Asia, Europe, North America|
Note that study-related documents posted on the COVID-19 Clinical Research Coalition (COVID-19 CRC) website have been shared by coalition members for information. Some may have been approved by Ethics Review Boards and others may still be in draft form. Documents posted here may have been further amended before being used in the conduct of the respective trials they were designed for. It is recommended that users review these documents carefully and, if they plan to use them, adapt them appropriately for their intended use. The COVID-19 CRC and its members cannot accept any liability for any claim, loss or damages as a result of any reliance placed on, or use of, these documents.